Orphazyme AS (CHIX:ORPHAC) 3-Year Book Growth Rate : 0.00% (As of Jun. 2022)

Competitive Comparison of Orphazyme AS's 3-Year Book Growth Rate

For the Biotechnology subindustry, Orphazyme AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orphazyme AS's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's 3-Year Book Growth Rate falls into.

Orphazyme AS 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Orphazyme AS  (CHIX:ORPHAc) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Orphazyme AS 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS (CHIX:ORPHAC) Business Description